.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cervical spondylotic myelopathy is often considered a surgical condition because ongoing cord compression can produce neurological decline. However, a randomized study of patients with mild or moderate, nonprogressive or slowly progressive disease compared conservative management with surgery over two years. The trial did not show a clear overall advantage for surgery in the primary neurological and gait outcomes during that period. This result applies to a carefully selected population and should not be extrapolated to patients with rapidly progressive deficits, severe myelopathy or major functional deterioration. For HCPs, the study highlights the importance of clinical trajectory. A patient with stable mild disease may reasonably undergo close monitoring and nonoperative management, whereas progressive weakness, gait decline or significant cord dysfunction changes the risk-benefit balance. The study also emphasises that treatment choice should be individualised and revisited over time. For clinicians, structured follow-up is essential because a conservative pathway only remains safe while neurological status remains stable.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Cervical spondylotic myelopathy is often considered a surgical condition because ongoing cord compression can produce neurological decline. However, a randomized study of patients with mild or moderate, nonprogressive or slowly progressive disease compared conservative management with surgery over two years. The trial did not show a clear overall advantage for surgery in the primary neurological and gait outcomes during that period. This result applies to a carefully selected population and should not be extrapolated to patients with rapidly progressive deficits, severe myelopathy or major functional deterioration. For HCPs, the study highlights the importance of clinical trajectory. A patient with stable mild disease may reasonably undergo close monitoring and nonoperative management, whereas progressive weakness, gait decline or significant cord dysfunction changes the risk-benefit balance. The study also emphasises that treatment choice should be individualised and revisited over time. For clinicians, structured follow-up is essential because a conservative pathway only remains safe while neurological status remains stable.
3 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
